Yahoo Web Search

Search results

1. Gossamer Bio, Inc.

   NasdaqGS: GOSS

   0.6700

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.0133 (-1.95%)

   At close: Tue. May 21, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	0.6867
     High	0.7100
     Low	0.6652

   • Mkt Cap	151.57M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	0.6833
     52 Wk. Low	0.4530
     52 Wk. High	1.8800

   More about GOSS

   Related stocks

   • ALEC
     Alector, Inc.
     ALEC
     5.39
     -0.37%
   • STOK
     Stoke Therapeutics, Inc.
     STOK
     15.35
     -4.66%
   • BCEL
     Atreca, Inc.
     BCEL
     0.1010
     +9.78%
   • BDTX
     Black Diamond Therapeutics, Inc.
     BDTX
     4.9700
     +1.43%
   • AKRO
     Akero Therapeutics, Inc.
     AKRO
     20.24
     +0.50%

   More on Yahoo Finance

2. Top Stories

   • Business Insider

     Buy Rating Reaffirmed for Gossamer Bio on Seralutinib’s Promising Clinical Data and Future Prospects

     Analyst Patrick Trucchio of H.C. Wainwright reiterated a Buy rating on Gossamer Bio (GOSS – Research Report), retaining the price target

     2 days ago

   • bovnews

     Gossamer Bio Inc (GOSS) Stock offers help to cash-strapped investors

     Wedbush raised the price target for the Gossamer Bio Inc (NASDAQ:GOSS) stock to “an Outperform”. The rating was released on April 05, 2024, according to finviz. We previously noted in another research note published on July 27,

     1 week ago

   • bovnews

     Gossamer Bio Inc (GOSS) Stock is Just Right Size-Neither Too Big Nor Too Small

     Wedbush raised the price target for the Gossamer Bio Inc (NASDAQ:GOSS) stock to “an Outperform”. The rating was released on April 05, 2024, according to finviz. We previously noted in another research note published on July 27,

     1 week ago

   • Investorplace News on MSN.com

     GOSS Stock Earnings: Gossamer Bio Misses EPS for Q1 2024

     GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires.

     2 weeks ago

   • Barron's on MSN.com

     AMC Stock Doubles. What Happens Now.

     1 week ago

   View all

3. finance.yahoo.com › quote › GOSSGossamer Bio, Inc. (GOSS) Latest Stock News & Headlines ...

   finance.yahoo.com › quote › GOSS

   • Cached

   Get the latest Gossamer Bio, Inc. (GOSS) stock news and headlines to help you in your trading and investing decisions.

   • Gossamer Bio Shares Plummet As Hypertension Trial Fall Short ...

     Tue, Dec 6, 2022, 10:00 AM 1 min read. In this article:...

   • Gossamer Bio, Inc. (GOSS) Stock Price, News, Quote & History ...

     Find the latest Gossamer Bio, Inc. (GOSS) stock quote,...

4. www.google.com › finance › quoteGossamer Bio Inc (GOSS) Stock Price & News - Google Finance

   www.google.com › finance › quote

   • Cached

   Get the latest Gossamer Bio Inc (GOSS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

5. People also ask

   Is gossamer bio (Goss) listed on the NASDAQ?

   • Gossamer Bio, Inc. is currently listed on NASDAQ under GOSS. One share of GOSS stock can currently be purchased for approximately $1.01. Is Gossamer Bio, Inc. listed on the NASDAQ or NYSE? Gossamer Bio, Inc. is listed on the NASDAQ as (NASDAQ:GOSS). What is Gossamer Bio, Inc.'s stock symbol?

   Gossamer Bio, Inc. (GOSS) Stock Price, Quote, News & Analysis

   seekingalpha.com/symbol/GOSS

   See all results for this question

   Does Gossamer Bio Inc (Goss) pay a dividend?

   • No significant news for in the past two years. GOSS is not currently paying a regular dividend. Closing Diaries View the latest Gossamer Bio Inc. (GOSS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

   GOSS | Gossamer Bio Inc. Stock Price & News - WSJ

   www.wsj.com/market-data/quotes/GOSS

   See all results for this question

   Is Goss stock a 50% sell?

   • Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review (s) in last seven days. We see that GOSS’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average.

   Selling Your Gossamer Bio Inc. (NASDAQ: GOSS) Stock? Here’s What Yo…

   stocksregister.com/2023/04/14/selling-your-gossamer-bio-inc-nasdaq-goss-stock-heres-what-you-need-to-know/

   See all results for this question

   Is Goss a good stock to buy?

   • 11 Wall Street analysts have issued ratings. Currently, 6 analysts rated GOSS as Bullish, 1 rated it Bearish, and 4 rated it Neutral. This suggests a possible increase. View GOSS’s analyst predictions.

   Gossamer Bio, Inc. (GOSS) Stock Price, Quote, News & Analysis

   seekingalpha.com/symbol/GOSS

   See all results for this question

6. stockanalysis.com › stocks › gossGossamer Bio, Inc. (GOSS) Stock Price, Quote & News - Stock ...

   stockanalysis.com › stocks › goss

   • Cached

   4 days ago · Shares of Gossamer Bio Inc. GOSS, +2.99% plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the company's experimental hypertension drug in a Phase ...

7. seekingalpha.com › symbol › GOSSGossamer Bio, Inc. (GOSS) Stock Price, Quote, News & Analysis

   seekingalpha.com › symbol › GOSS

   • Cached

   May 10, 2024 · A high-level overview of Gossamer Bio, Inc. (GOSS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

8. www.wsj.com › market-data › quotesGOSS | Gossamer Bio Inc. Stock Price & News - WSJ

   www.wsj.com › market-data › quotes

   • Cached

   View the latest Gossamer Bio Inc. (GOSS) stock price, news, historical charts, analyst ratings and financial information from WSJ.